238 related articles for article (PubMed ID: 2475030)
21. A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
Matozaki T; Martinez J; Williams JA
Am J Physiol; 1989 Oct; 257(4 Pt 1):G594-600. PubMed ID: 2478032
[TBL] [Abstract][Full Text] [Related]
22. High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats.
Li Y; Hao Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G679-85. PubMed ID: 9316472
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
[TBL] [Abstract][Full Text] [Related]
25. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
Yoshida H; Tsunoda Y; Owyang C
Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
[TBL] [Abstract][Full Text] [Related]
26. Carbachol desensitizes pancreatic enzyme secretion by downregulation of receptors.
Vinayek R; Murakami M; Sharp CM; Jensen RT; Gardner JD
Am J Physiol; 1990 Jan; 258(1 Pt 1):G107-21. PubMed ID: 1689117
[TBL] [Abstract][Full Text] [Related]
27. Low-affinity CCK-1 receptors inhibit bombesin-stimulated secretion in rat pancreatic acini--implication of the actin cytoskeleton.
Kiehne K; Herzig KH; Otte JM; Fölsch UR
Regul Pept; 2002 May; 105(2):131-7. PubMed ID: 11891013
[TBL] [Abstract][Full Text] [Related]
28. The regulatory site of functional GTP binding protein coupled to the high affinity cholecystokinin receptor and phospholipase A2 pathway is on the G beta subunit of Gq protein in pancreatic acini.
Tsunoda Y; Owyang C
Biochem Biophys Res Commun; 1995 Jun; 211(2):648-55. PubMed ID: 7540841
[TBL] [Abstract][Full Text] [Related]
29. Characterization of gastrin receptors on guinea pig pancreatic acini.
Yu DH; Noguchi M; Zhou ZC; Villanueva ML; Gardner JD; Jensen RT
Am J Physiol; 1987 Dec; 253(6 Pt 1):G793-801. PubMed ID: 2447788
[TBL] [Abstract][Full Text] [Related]
30. High-affinity cholecystokinin type A receptor/cytosolic phospholipase A2 pathways mediate Ca2+ oscillations via a positive feedback regulation by calmodulin kinase in pancreatic acini.
Lankisch TO; Nozu F; Owyang C; Tsunoda Y
Eur J Cell Biol; 1999 Sep; 78(9):632-41. PubMed ID: 10535305
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
Lignon MF; Bernad N; Martinez J
Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
[TBL] [Abstract][Full Text] [Related]
32. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
33. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
34. Pancreas growth, tyrosine kinase, PtdIns 3-kinase, and PLD involve high-affinity CCK-receptor occupation.
Rivard N; Rydzewska G; Lods JS; Martinez J; Morisset J
Am J Physiol; 1994 Jan; 266(1 Pt 1):G62-70. PubMed ID: 8304459
[TBL] [Abstract][Full Text] [Related]
35. Caffeine inhibits a low affinity but not a high affinity mechanism for cholecystokinin-evoked Ca2+ signalling and amylase release from guinea pig pancreatic acini.
Sjödin L; Gylfe E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):113-9. PubMed ID: 10685865
[TBL] [Abstract][Full Text] [Related]
36. Structural requirements of CCK analogues to differentiate second messengers and pancreatic secretion.
Tsunoda Y; Yoshida H; Owyang C
Am J Physiol; 1996 Jul; 271(1 Pt 1):G8-19. PubMed ID: 8760101
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of CCK-JMV-180 on food intake in rats and mice.
Asin KE; Bednarz L
Pharmacol Biochem Behav; 1992 Jun; 42(2):291-5. PubMed ID: 1631182
[TBL] [Abstract][Full Text] [Related]
38. Effects of cholecystokinin, cholecystokinin JMV-180 and GTP analogs on enzyme secretion from permeabilized acini and chloride conductance in isolated zymogen granules of the rat pancreas.
Piiper A; Plusczyk T; Eckhardt L; Schulz I
Eur J Biochem; 1991 Apr; 197(2):391-8. PubMed ID: 1902787
[TBL] [Abstract][Full Text] [Related]
39. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT
Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984
[TBL] [Abstract][Full Text] [Related]
40. CCK-JMV-180, an analog of cholecystokinin, releases intracellular calcium from an inositol trisphosphate-independent pool in rat pancreatic acini.
Saluja AK; Dawra RK; Lerch MM; Steer ML
J Biol Chem; 1992 Jun; 267(16):11202-7. PubMed ID: 1375937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
